GENE ONLINE|News &
Opinion
Blog

2024-03-28|

Previewing AACR 2024 With Select Pre-Meeting Highlights

by Bernice Lottering
Share To
Source: AACR

American Association for Cancer Research, 2024 Annual Meeting

The AACR Annual Meeting 2024 is scheduled to take place at the San Diego Convention Center in California, running from April 5th to April 10th. Taking place every year, the AACR Annual Meeting serves as the central hub for the cancer research community, bringing together scientists, clinicians, healthcare professionals, survivors, patients, and advocates to exchange the most recent breakthroughs in cancer science and medicine. This year’s rich program spans the breadth of oncology, encompassing advancements in population science, prevention, cancer biology, translational and clinical studies, as well as survivorship and advocacy. It showcases the innovative work of leading researchers and medical professionals from institutions across the globe.

GeneOnline will conduct a special report on the AACR. The following table is a preview of some of the exciting content to be shared.

2024 AACR Select Research Highlights by Oscar Wu, GeneOnline

With approximately 22 000 attendees, 630 speakers and 450 exhibitors, present throughout the 6 day conference, the AACR Annual meeting promises to be a rich source of information within the oncology field. Featuring educational conferences, specialized courses, workshop lectures, special forums and educational materials, this ground-breaking comprehensive content is something not to be missed.

Reference: AACR Official Website

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
IPO
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Merck Strikes $1.3 Billion Deal to Acquire Curon’s B-Cell Therapy Drug
2024-08-12
ASCO Breakthrough 2024: Radiation Alone Works as Well as Chemoradiation for Low-Risk Nasopharyngeal Cancer
2024-08-08
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top